|
Trans-Agency (Medical) Imaging Phantom (TAIP) Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI, NIBIB
|
A common set of scientifically validated medical phantoms that have long term curation, convenient dissemination, associated measurement protocols and analysis software, will be of great benefit to the FDA, NIH, NIST and to the scientific community they serve. This working group is created to enhance collaboration between FDA, NIST, and NIH to cooperate, where possible, on the development, validation, and dissemination of these medical calibration objects and to maintain at library of these medical phantoms for use by the larger medical community.
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, CDC, FDA
|
NIAID
|
The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us.” The objectives of the Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) are to increase the mutual understanding of US and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration in order to deepen the transatlantic dialogue, provide opportunities to learn from each other, and promote information exchange, coordination, and cooperation.
|
|
Trans-Federal Animal Genomics Program Officers Working Group
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NCI, NHGRI, NICHD, NIGMS
|
Coordinates research in animal genomics across multiple federal agencies.
|
|
Trans-NIH Biomedical Technology and Engineering Collective Meeting (bTEC)
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
ARPA-H, CSR, FIC, NCATS, NCI, NEI, NHLBI, NIA, NIAID, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, OD/All of Us
|
The Trans-NIH Biomedical Technology and Engineering Collective (bTEC) is a collective (or working group) concentrating on areas of common interests and concerns within Extramural Engineering programs at NIH
|
|
Trans-NIH Liver Cancer Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NCI, NCMHD, NIAAA, NIAID, NIDDK
|
The charge of this working group is to develop an integrated NIH-wide plan for research in liver cancer that addresses basic, behavioral, translational, and clinical aspects of liver cancer aimed at understanding the basic mechanisms, the prevention, and cure of the disease. Additionally, the working group is interested in global health and health disparities research on liver disease. Other collaborative activities: meeting/workshop, public education campaign
|
|
Trans-NIH Mitochondrial Disorders Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIEHS, NIGMS, NIMH, NINDS
|
The Trans-NIH Mitochondrial Disorders Working Group meets every 2-3 years to discuss and share information about ongoing funded research related to mitochondrial disorders including mechanisms and therapies.
|
|
Trans-NIH Regenerative Medicine Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NEI, NIAMS
|
Building new AMP program in cell-based therapies.
|
|
Transboundary Animal Disease Threats Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
interagency working group under the HST subcommittee to continue its work to address agricultural research and development gaps as they pertain to transboundary animal disease threats to U.S. livestock and emerging diseases in animals that may impact public health.
|
|
Translational Science Interagency Fellowship (TSIF)
|
Training Initiative
|
FDA
|
NCATS
|
The Translational Science Interagency Fellowship (TSIF) program is a three-year postdoctoral fellowship opportunity jointly sponsored by the National Center for Advancing Translational Science (NCATS) and the U.S. Food and Drug Administration (FDA). The program aims to provide training in both translational science and regulatory science. The common goal of NCATS and the FDA is to bring safe and effective drugs, regimens, and devices from bench-to-bedside as quickly and efficiently as possible. To that end, fellows are trained in preclinical translational science, technology development, and regulatory research and review. By combining training in translational science and research-related regulatory review, the program enables fellows to build awareness of regulatory requirements into the early stages of medical product development thereby improving efficiencies in both the development and review processes. Fellows in this program will develop valuable skills for future careers in academia, the pharmaceutical industry, and government.
|
|
Transplant Cancer Match Study
|
Research Initiative
|
HRSA
|
NCI
|
A study linking databases of US transplant recipients, donors, and waitlist candidates to multiple US cancer registries to evaluate the spectrum of cancer risk and outcomes in the transplant population.
|